SCHEMBL19610487

SCHEMBL19610487

CC(C)c1cc(-c2cc(C(C)C)c(CC(=O)O)c(C(C)C)c2)c(CC(=O)O)c(C(C)C)c1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
FABP3 P05413 2/20 0.46
FABP4 P15090 2/20 0.46
SOAT2 O75908 1/20 0.40
MYC P01106 1/20 0.40
SOAT1 P35610 1/20 0.40
MAP2K3 P46734 1/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
FABP5 Q01469 1/20 0.38
GABRA1 P14867 1/20 0.36
GABRB2 P47870 1/20 0.36
HMGCR P04035 2/20 0.33
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
THRA P10827 3/20 0.32
THRB P10828 3/20 0.32
AGBL2 Q5U5Z8 1/20 0.32
NLRP3 Q96P20 1/20 0.32
USP5 P45974 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8137246 0.88 FABP3 (0.57) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL19610490 0.83 CA1 (0.46) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL20681236 0.77 FABP3 (0.43) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL19610475 0.77 CA1 (0.61) GAAGABRA1GABRB2CA1CA2
SCHEMBL20699064 0.74 KDM4E (0.44) FABP3FABP4KDM4EGAATHRA
SCHEMBL20698934 0.74 AURKA (0.44) KDM4EGAATHRATHRB
SCHEMBL20681232 0.73 GABRA1 (0.50) FABP3FABP4KDM4EGAAGABRA1
SCHEMBL19475246 0.73 GABRA1 (0.50) FABP3FABP4KDM4EGAAGABRA1
SCHEMBL8136292 0.73 FABP4 (0.50) FABP3FABP4SOAT2MYCSOAT1
SCHEMBL19475203 0.73 NLRP3 (0.41) FABP3FABP4KDM4EGAATHRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200179302-A1 USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2020-06-11 US disclosed
US-10329243-B2 Biphenyl derivative and uses thereof XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2019-06-25 US disclosed
US-20180185299-A1 THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2018-07-05 US disclosed
US-20180141895-A1 DIPHENYL DERIVATIVE AND USES THEREOF XI'AN LIBANG PHARMACEUTICAL CO., LTD (CN) 2018-05-24 US disclosed
EP-3246022-A1 THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA Xi'an Libang Pharmaceutical Co., Ltd (CN) 2017-11-22 EP disclosed
EP-3246304-A2 DIPHENYL DERIVATIVE AND USES THEREOF Xi'an Libang Pharmaceutical Co., Ltd (CN) 2017-11-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200179302-A1 USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA PTGER3, PTGES3, CYP24A1 FABP3 11/4885FABP4 2616/4885SOAT2 2285/4885
US-10329243-B2 Biphenyl derivative and uses thereof PPARD, PCSK9, UGT2B7 FABP3 15/4885FABP4 258/4885SOAT2 987/4885
US-20180141895-A1 DIPHENYL DERIVATIVE AND USES THEREOF PPARD, DPP3, DPP7 FABP3 46/4885FABP4 629/4885SOAT2 1760/4885
US-20180185299-A1 THE USE OF DIPHENOL IN PREPARATION OF MEDICINES FOR PREVENTION AND TREATMENT OF CEREBRAL ISCHEMIA PTGER3, CYP24A1, PTGES3 FABP3 9/4885FABP4 2475/4885SOAT2 2296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.